Mahesh Kumar Gundluru

This inventor holds 12 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Arbor Therapeutics, LLC, Case Western Reserve University, Invenio Therapeutics Inc.. Active years: 2013-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mahesh Kumar Gundluru. Retrieved from https://idiyas.com/inventor/mahesh-kumar-gundluru

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 1)

% Patents Active = 58.3

CIPO Patents = 1

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 10(Granted Patents)

Location History:

Cordova, TN (US) (2013 - 2018)
Louisville, KY (US) (2019)
Cordova, TN (2019)
Lexington, KY (US) (2017 - 2020)

Company Filing History:

5 out of 6

Arbor Therapeutics, LLC

patents

2 out of 1,364

Case Western Reserve University

patents

1 out of 1

Invenio Therapeutics Inc.

patent

4. 1 out of 1

Mirx Pharmaceuticals, LLC

patent

5. 1 out of 3

Veiled Therapeutics LLC

patents

6. 2 out of 834,513

Other

patents

Years Active: 2013-2020

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10806723 - Securinine and norsecurinine analogue compounds for the treatment of myeloid disorders (2020-10-20),

2. 10183912 - HDMX inhibitors and their use for cancer treatment (2019-01-22),

3. 10172957 - Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents (2019-01-08),

4. 10149838 - Small molecule securinine and norsecurinine analogs and their use in inhibiting myeloperoxidase (2018-12-11),

5. 10130616 - Securinine and norsecurinine analogue compounds for the treatment of myeloid disorders (2018-11-20),

6. 9889201 - Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents (2018-02-13),

7. 9827229 - Small molecule securinine and norsecurinine analogs and their use in cancers, inflammatory diseases and infections (2017-11-28),

8. 9339555 - Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents (2016-05-17),

9. 9227983 - Taxane and abeo-taxane analogs (2016-01-05),

10. 8912229 - Taxane and abeo-taxane analogs (2014-12-16),

11. 8716328 - Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents (2014-05-06),

12. 8440714 - Acid-labile lipophilic prodrugs of cancer chemotherapeutic agents (2013-05-14),

Title: Mahesh Kumar Gundluru - Innovative Mind from Cordova

Introduction: Mahesh Kumar Gundluru is a talented inventor based in Cordova, Tennessee. His passion for innovation and problem-solving has led him to create groundbreaking inventions in various fields.

Latest Patents: Mahesh Kumar Gundluru holds several patents in his name, showcasing his continuous dedication to developing new technologies and solutions to real-world challenges.

Career Highlights: With a background in engineering, Mahesh Kumar Gundluru has had a successful career marked by his ability to think outside the box. His innovative spirit has driven him to push the boundaries of what is possible in the world of inventions.

Collaborations: Mahesh Kumar Gundluru has collaborated with leading research institutions and universities to further his inventions. His collaborative efforts have resulted in cutting-edge technologies that have the potential to make a significant impact on society.

Conclusion: Mahesh Kumar Gundluru's inventive prowess and commitment to innovation make him a standout figure in the world of inventors. His contributions have the potential to shape the future and inspire the next generation of innovators.

Profile summary based on public USPTO records.